Table of Contents Table of Contents
Previous Page  17 / 21 Next Page
Information
Show Menu
Previous Page 17 / 21 Next Page
Page Background

THE GEC ESTROHANDBOOKOF BRACHYTHERAPY | Part I: The Basics of Brachytherapy

Version 1 - 22/10/2015

Radiobiology of LDR, HDR, PDR and VLDR Brachytherapy

17

Practical example 8:

EQD2 calculation of a standard cervix cancer treatment with

HDR boost

A standard schedule for cervix cancer treatment is external

beam RT of 45 Gy in 1.8 Gy fractions, with concomitant cispla-

tin ,followed by an intracavitary (interstitial) boost of 4 times 7

Gy HDR. The total absorbed dose of 45 Gy delivered with EBRT

corresponds to an EQD2 of 43.2 Gy assuming α/β = 3 Gy and

44.3 Gy assuming α/β = 10 Gy. The 4 fractions of 7 Gy corre-

spond to an EQD2 of 56 Gy assuming α/β = 3 Gy and 39.7 Gy

assuming α/β = 10 Gy. As the EQD2 delivered by EBRT and BT

are additive, the total EQD2 is thus 99.2 Gy assuming α/β = 3 Gy

and 84 Gy assuming α/β = 10 Gy.

Practical example 9:

EQDS calculation of a standard cervix cancer treatment with

PDR boost

A standard schedule for cervix cancer treatment is 45 Gy in

1.8Gy fractions with concomitant cisplatin, followed by a PDR

BT boost delivering 40 Gy in 80 pulses of 0.5 Gy. The duration of

the single PDR course is 3.5 days. As in the calculation of EQD2,

only the dose per fraction and T

1/2

are taken into account. The

EQD2 of the single PDR is 41 Gy assuming α/β = 3 Gy and 40.4

Gy assuming α/β = 10 Gy. A T

1/2

value of 1.5 h is used for the

computation. The total EQD2 doses of combining EBRT and BT

are 84.2 Gy assuming α/β = 3 Gy and 84.7 Gy assuming α/β =

10 Gy.

11.

KEY MESSAGES

• Brachytherapy (BT) differs from external beam therapy (EBRT) in two main ways: the distribution of the absorbed dose and the

time-dose patterns.

• The dose is prescribed to an isodose surface encompassing a CTV volume of ~20 - 200 cm

3

. The GTV receives about >150% of

the prescribed dose.

• Brachytherapy uses different dose rates, divided, somewhat arbitrarily, into three ranges:

low-dose rate

(LDR) < 1 Gy h

-1

,

medium

dose

rate

(MDR) between 1 and 12 Gy h

-1

and

high-dose rate

(HDR) >12 Gy h

-1

.

• Changing dose rate in the MDR range causes the most pronounced changes in biological effect.

• The LQ formalism and EQDX allow comparison of the predicted effects of a particular BT schedule with other BT and external

beam schedules, with regard to both tumour control and normal tissue effects. This formalism can be safely applied within a

range of doses per fraction from 0.5 Gy to 6-10 Gy; it might, however, potentially overestimate the effects at higher doses per

fraction.

• Because of historical precedents and clinical experience EQD2 referring to photon doses of 2Gy /fraction is commonly used.

For protocols involving different tissues assumed values of α/β and half time of repair (T

1/2

) are required for both radiation types

and must be specified.